Literature DB >> 6967340

An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1).

H P Koeffler, R Billing, A J Lusis, R Sparkes, D W Golde.   

Abstract

A variant subline (KG-1a) of the human acute myelogenous leukemia (AML) cell line (KG-1) has been isolated. The cells retain the same constitutive markers as the parent line, including HLA antigens, isoenzymes, and karyotype. The cells from the subline are morphologically and histochemically undifferentiated blast cells, while the parent cells and several of its clones are at the myeloblast and promyelocyte stages of development. The variant cells do not respond to colony-stimulating factor (CSF), and they do not express the human la antigen, nor a recently characterized AML antigen. The parent KG-1 cells are stimulated to proliferate in the presence of CSF and the cells express the la and AML antigen. Variant AML cell lines, such as KG-1a, will be useful in vitro models for investigating cellular response to CSF and for studying antigen expression in leukemic cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967340

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  High affinity and covalent-binding microtubule stabilizing agents show activity in chemotherapy-resistant acute myeloid leukemia cells.

Authors:  Benet Pera; M Nieves Calvo-Vidal; Srikanth Ambati; Michel Jordi; Alissa Kahn; J Fernando Díaz; Weishuo Fang; Karl-Heinz Altmann; Leandro Cerchietti; Malcolm A S Moore
Journal:  Cancer Lett       Date:  2015-08-12       Impact factor: 8.679

2.  Regulation of RelB expression during the initiation of dendritic cell differentiation.

Authors:  Pedro J Cejas; Louise M Carlson; Despina Kolonias; Jian Zhang; Inna Lindner; Daniel D Billadeau; Lawrence H Boise; Kelvin P Lee
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

3.  Development of analytical methods for multiplex bio-assay with inductively coupled plasma mass spectrometry.

Authors:  Olga I Ornatsky; Robert Kinach; Dmitry R Bandura; Xudong Lou; Scott D Tanner; Vladimir I Baranov; Mark Nitz; Mitchell A Winnik
Journal:  J Anal At Spectrom       Date:  2008       Impact factor: 4.023

4.  G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells.

Authors:  T T Amatruda; D A Steele; V Z Slepak; M I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

5.  Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance.

Authors:  Xiangwen Chen-Deutsch; George P Studzinski
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

6.  Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells.

Authors:  D S Cowen; H M Lazarus; S B Shurin; S E Stoll; G R Dubyak
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

7.  Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

Authors:  Elodie Lainey; Marie Sébert; Sylvain Thépot; Marie Scoazec; Cyrielle Bouteloup; Carole Leroy; Stéphane De Botton; Lorenzo Galluzzi; Pierre Fenaux; Guido Kroemer
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

8.  Monoclonal antibodies reactive with human myeloid leukaemia cells.

Authors:  E D Ball; M W Fanger
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

9.  Local and metastatic growth and in vivo differentiation of human myeloid leukemia cells transplanted in nude mice.

Authors:  E A Machado; D A Gerard
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

10.  Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.

Authors:  A Mario Marcondes; Andrew J Mhyre; Derek L Stirewalt; Soo-Hyun Kim; Charles A Dinarello; H Joachim Deeg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.